GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Operating Margin %

Veritas In Silico (TSE:130A) Operating Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Veritas In Silico's Operating Income for the three months ended in Dec. 2024 was 円0.0 Mil. Veritas In Silico's Revenue for the three months ended in Dec. 2024 was 円0.0 Mil. Therefore, Veritas In Silico's Operating Margin % for the quarter that ended in Dec. 2024 was 0.00%.

The historical rank and industry rank for Veritas In Silico's Operating Margin % or its related term are showing as below:

TSE:130A' s Operating Margin % Range Over the Past 10 Years
Min: -396.95   Med: -93.4   Max: 10.44
Current: -34.89


TSE:130A's Operating Margin % is ranked better than
62.9% of 992 companies
in the Biotechnology industry
Industry Median: -127.94 vs TSE:130A: -34.89

Veritas In Silico's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Veritas In Silico's Operating Income for the three months ended in Dec. 2024 was 円0.0 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was 円-68.8 Mil.


Veritas In Silico Operating Margin % Historical Data

The historical data trend for Veritas In Silico's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Operating Margin % Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Operating Margin %
-396.95 -77.50 10.44 -109.30

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24
Operating Margin % Get a 7-Day Free Trial - -2.51 -202.15 -2.04 -

Competitive Comparison of Veritas In Silico's Operating Margin %

For the Biotechnology subindustry, Veritas In Silico's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veritas In Silico's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's Operating Margin % falls into.


;
;

Veritas In Silico Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Veritas In Silico's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=-212.74 / 194.643
=-109.30 %

Veritas In Silico's Operating Margin % for the quarter that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=0 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veritas In Silico  (TSE:130A) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Veritas In Silico Operating Margin % Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines